BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
ID: CBRND-BAA-22-01Type: Solicitation
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW6QK ACC-APGABERDEEN PROVING GROU, MD, 21010-5424, USA

PSC

NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH (AC12)

Original Source

https://sam.gov/opp/66870bda25274773b3e5fa7cfd3c0e11/view
Timeline
  1. 1
    Posted Jun 11, 2022, 6:07 PM UTC
  2. 2
    Updated May 26, 2023, 3:07 PM UTC
  3. 3
    Due Jun 11, 2027, 4:00 AM UTC
Description

Solicitation DEPT OF DEFENSE is seeking research and development services in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), JPM Medical and JPL EB. The service being procured is for the identification of the best available science in the areas of research interest, including novel solutions and improved methods for developing medical countermeasures. The government is specifically interested in enabling technologies, life cycle bioinformatics, and improved logistics tracking. The procurement notice is available on SAM.gov and the JPEO-CBD website. Potential offerors are encouraged to communicate with the JPMO technical contacts for proposal ideas. For any questions or inquiries, contact usarmy.detrick.mcs.mbx.baa@mail.mil.

Point(s) of Contact
Richard Totten
(301) 619-2446
richard.w.totten2.civ@army.mil
Files
Title
Posted
W911SR-22-R-CBRND BAA 11 Jun 22.pdf
Mar 28, 2024, 7:16 AM UTC
The Army Contracting Command at Aberdeen Proving Ground has issued a Broad Agency Announcement (BAA) for research and development efforts supporting the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND). Proposals are solicited from eligible organizations, including educational institutions and private industry, focusing on advanced medical countermeasures and enabling technologies for CBRN threats, with awards potentially involving procurement contracts, grants, or other transaction agreements. The announcement provides comprehensive guidelines for proposal submission, evaluation criteria, and administrative details for applicants.
Similar Opportunities
JPEO-CBRND CWMD BOTAA-24-01
Buyer not available
Special Notice DEPT OF DEFENSE DEPT OF THE ARMY: The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) is seeking funding through Other Transaction Authority agreements (OTAs) for prototype and follow-on production projects within JPEO-CBRND mission areas of interest. The service being procured is the development of enabling technologies that speed up the advanced development process. This opportunity is open to all eligible sources, including educational institutions, nonprofit organizations, and private industry. Proposals are to be submitted in accordance with the provided guidelines. For more information, please refer to the JPEO-CBRND website.
BROAD AGENCY ANNOUNCEMENT (BAA) FOR CHEMICAL BIOLOGICAL RADIOLOGICAL NUCLEAR AND EXPLOSIVE (CBRNE) DEFENSE EFFORTS UNDER PROCUREMENT CONTRACTS, COOPERATIVE AGREEMENTS, AND PROTOTYPES UNDER OTHER TRANSACTIONS AGREEMENTS
Buyer not available
The Department of Defense, through the Army Contracting Command at Aberdeen Proving Ground, has issued a Broad Agency Announcement (BAA) for Chemical Biological Radiological Nuclear and Explosive (CBRNE) defense efforts. This solicitation invites proposals from a diverse range of eligible sources, including educational institutions and private industry, to advance innovative research and development in areas such as sensor technologies, decontamination methods, and biological detection systems. The BAA aims to enhance military effectiveness and support homeland defense through various award mechanisms, including Procurement Contracts, Prototype Other Transactions, and Cooperative Agreements. Interested parties should contact Marc Lukaszewicz at marc.s.lukaszewicz.civ@army.mil or Lionel Love at lionel.d.love.civ@army.mil for further details, and adhere to the proposal submission guidelines outlined in the solicitation document.
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
Buyer not available
The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Broad Agency Announcement (BAA) BAA-23-100-SOL-00004 for advanced research and development of Medical Countermeasures (MCMs) aimed at addressing public health threats such as chemical, biological, radiological, and nuclear (CBRN) incidents, as well as emerging infectious diseases and pandemic influenza. The initiative seeks to foster public-private partnerships to enhance the development and responsiveness of life-saving MCMs, emphasizing the importance of technological maturity, regulatory compliance, and manufacturing standards in the evaluation process. This opportunity is critical for strengthening national health security and improving preparedness for future public health emergencies, with an open submission period running until September 25, 2028, at 4:30 PM Eastern Time. Interested parties can direct inquiries to BARDA-BAA@hhs.gov for further information.
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
Buyer not available
Special Notice DEPT OF DEFENSE is seeking proposals for extramural biomedical research and development. This opportunity is issued by the DEFENSE HEALTH AGENCY (DHA) under the BROAD AGENCY ANNOUNCEMENT (BAA) HT9425-23-S-SOC1. The purpose of this BAA is to solicit research and development ideas to advance the state-of-the-art or increase knowledge in the field. The projects funded under this BAA should focus on basic and applied research rather than the development of specific systems or hardware solutions. The research and development funding is expected to benefit both military and civilian medical practice and knowledge. Interested parties must submit a pre-proposal through the electronic Biomedical Research Application Portal (eBRAP). If selected, the offeror will be invited to submit a full proposal or application through Grants.gov. The BAA is open for a 5-year period, from August 1, 2023, to July 31, 2028. The BAA with revised research areas of interest and General Submission Instructions can be found on Grants.gov using opportunity number HT9425-23-S-SOC1.
DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA
Buyer not available
Special Notice: DEPT OF DEFENSE DEPT OF THE ARMY is seeking extramural research and development ideas for medical research. The USAMRDC aims to provide solutions to medical problems for the American Service Member and the general public. This BAA solicits basic and applied research projects to advance medical science and technology. The selection process is highly competitive, and submissions are accepted throughout a 5-year period. Pre-proposals must be submitted through the electronic Biomedical Research Application Portal (eBRAP), and invited full proposals must be submitted through Grants.gov.
DHS BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT (R&D) COUNTERING WEAPONS OF MASS DESTRUCTION (CWMD)
Buyer not available
Solicitation: Department of Homeland Security (DHS) is seeking Research and Development (R&D) proposals for countering Weapons of Mass Destruction (CWMD). The objective is to identify, explore, and demonstrate new technologies and capabilities to prevent, protect against, respond to, and mitigate nuclear, chemical, radiological, and biological threats and incidents. This 5-year Broad Agency Announcement (BAA) will provide an acquisition tool for innovative solutions. Proposals will be accepted within specified timeframes for various Areas of Interest (AOI) outlined in the notice. Interested parties can find more information on SAM.gov.
ACC-APG Competitive Opportunities: Edgewood Contracting Division February 2025 update
Buyer not available
The Department of Defense, through the ACC-APG Edgewood Contracting Division, is announcing upcoming competitive opportunities related to chemical and biological defense technologies, with updates expected in February 2025. The procurement will focus on initiatives from the Joint Product Executive Office for Chemical, Biological, Radiological, Nuclear Defense (JPEO CBRND), including projects such as Colorimetric Indicator Detection Technologies and Tactical Water Purification Systems, alongside public affairs and program support services. These efforts are crucial for enhancing the U.S. military's capabilities in addressing chemical and biological threats, while also fostering collaboration with industry and academia through technology transfer agreements. Interested vendors should refer to the provided documents for specific guidelines, anticipated contract values ranging from $250,000 to over $100 million, and upcoming deadlines, including an Industry Day scheduled for June 2025 at Aberdeen Proving Ground.
Using Protease Cascades to Detect Protein Targets
Buyer not available
The Department of Defense, through the Army Medical Research Acquisition Activity, is seeking to award a sole source contract to Potomac Affinity Proteins, LLC for the development and testing of a protease cascade designed to detect protein targets in environmental samples. This innovative research requirement involves the use of target-specific antibodies or related ligands to aggregate protein targets and initiate a signal cascade, which is critical for advancing biotechnology applications in health and safety. The contract will be awarded without further competition unless other capable sources respond by the deadline of 12:00 PM EST on May 6, 2025, with evidence of their ability to meet the requirements. Interested parties should direct their inquiries to Tara Borntreger at tara.j.borntreger.civ@health.mil or Jayme Fletcher at jayme.l.fletcher2.civ@health.mil.
Generally Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners
Buyer not available
The Department of Defense, specifically the U.S. Army, is seeking collaboration with qualified entities for the Generally Unconstrained Intelligence Drug Engineering (GUIDE) program, aimed at accelerating the development of medical countermeasures for warfighters. This initiative involves a partnership among U.S. interagency, academic, and industry stakeholders to leverage advanced simulation and machine learning technologies for the rapid design and optimization of biological products and small molecule drugs. The GUIDE program is critical for enhancing the preparedness and response capabilities against diverse threats, and interested parties must demonstrate technical relevance by contacting the primary point of contact, Joseph McCaffery, at joseph.w.mccaffery2.civ@army.mil. Participation is governed by a Participant Basic Agreement (PBA), and entities must be registered in the System for Award Management (SAM) prior to any award.
BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
Buyer not available
The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Easy Broad Agency Announcement (EZ-BAA) BAA-22-100-SOL-00003, which focuses on innovative research to enhance public health preparedness against various biomedical threats. The initiative encompasses multiple Areas of Interest (AOIs), including the development of medical countermeasures for emerging infectious diseases, repurposing existing drugs for chemical threats, and advancing technologies for at-home diagnostics. Interested parties must have active registration with SAM.gov and are encouraged to engage in pre-submission consultations; abstract submissions are due by specified deadlines, with funding amounts contingent on the quality of proposals and alignment with program goals. For further inquiries, interested vendors can contact the BARDA DCMA DRIVe Team at DRIVeAcquisitions@hhs.gov.